NCT02643342

Brief Summary

This is a two-year longitudinal study investigating the optical and structural effects of increased compression factor of orthokeratology lens on eyes and the corresponding effect on change in choroidal thickness and therefore myopic control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 31, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

June 18, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 3, 2019

Completed
Last Updated

July 30, 2020

Status Verified

February 1, 2020

Enrollment Period

3.1 years

First QC Date

December 28, 2015

Last Update Submit

July 29, 2020

Conditions

Keywords

myopia controlorthokeratology

Outcome Measures

Primary Outcomes (1)

  • Axial length

    axial progression of the eyeball

    every 6 monthly in 2 years

Secondary Outcomes (4)

  • Ocular aberration measured by Complete Ophthalmic Analysis System (COAS) aberrometer

    every 6 monthly in 2 years

  • Corneal biomechanics (corneal response using ocular response)

    every 6 monthly in 2 years

  • Accommodation lag measured by Complete Ophthalmic Analysis System (COAS) aberrometer

    every 6 monthly in 2 years

  • Choroidal thickness captured by Optical Coherent Tomographer (OCT)

    every 6 monthly in 2 years

Study Arms (3)

Single-vision glasses

NO INTERVENTION

Subjects wearing single-vision glasses CR-39 of refractive index 1.56.

Orthokeratology with normal compression factor

SHAM COMPARATOR

Subjects wearing orthokeratology lenses of normal compression factor about 0.50-0.75D.

Device: Orthokeratology

Orthokeratology with increased compression factor

ACTIVE COMPARATOR

Subjects wearing orthokeratology lenses of increased compression factor about 1.50-1.75D.

Device: Orthokeratology

Interventions

Also known as: ortho-k
Orthokeratology with increased compression factorOrthokeratology with normal compression factor

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • to 10 years old
  • Myopia: between 0.50 D and 4.00 D in both eyes
  • Astigmatism: \<1.50 D; ≤ 1.25 D for with-the-rule astigmatism (axes 180 ± 30); ≤ 0.50 D for astigmatism of other axes in both eyes
  • Anisometropia: ≤ 1.50 D
  • Symmetrical corneal topography with corneal toricity \<2.00 D in both eyes
  • Agree for randomization

You may not qualify if:

  • Contraindications for orthokeratology wear (e.g. limbus-to-limbus corneal cylinder and dislocated corneal apex)
  • Any type of strabismus or amblyopia
  • Myopic treatment (e.g. refractive surgery and progressive lens wear for myopic control) before and during the study period
  • Rigid contact lenses (including orthokeratology lenses) experience
  • Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)
  • Ocular conditions which might affect the refractive error (for example, cataract, ptosis)
  • Poor compliance for lens wear or follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Optometry, The Hong KOng Polytechnic University

Hong Kong, China

Location

Related Publications (9)

  • Lam CS, Lam CH, Cheng SC, Chan LY. Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades. Ophthalmic Physiol Opt. 2012 Jan;32(1):17-24. doi: 10.1111/j.1475-1313.2011.00886.x.

    PMID: 22150587BACKGROUND
  • Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005 Jan;30(1):71-80. doi: 10.1080/02713680590907256.

    PMID: 15875367BACKGROUND
  • Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. doi: 10.1167/iovs.12-10565.

    PMID: 22969068BACKGROUND
  • Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013 Oct 3;54(10):6510-7. doi: 10.1167/iovs.13-12527.

    PMID: 24003088BACKGROUND
  • Gonzalez-Meijome JM, Villa-Collar C, Queiros A, Jorge J, Parafita MA. Pilot study on the influence of corneal biomechanical properties over the short term in response to corneal refractive therapy for myopia. Cornea. 2008 May;27(4):421-6. doi: 10.1097/ICO.0b013e318164e49d.

    PMID: 18434845BACKGROUND
  • Wolffsohn JS, Safeen S, Shah S, Laiquzzaman M. Changes of corneal biomechanics with keratoconus. Cornea. 2012 Aug;31(8):849-54. doi: 10.1097/ICO.0b013e318243e42d.

    PMID: 22495031BACKGROUND
  • Tse DY, Lam CS, Guggenheim JA, Lam C, Li KK, Liu Q, To CH. Simultaneous defocus integration during refractive development. Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5352-9. doi: 10.1167/iovs.07-0383.

    PMID: 18055781BACKGROUND
  • Chan B, Cho P, Mountford J. The validity of the Jessen formula in overnight orthokeratology: a retrospective study. Ophthalmic Physiol Opt. 2008 May;28(3):265-8. doi: 10.1111/j.1475-1313.2008.00545.x.

    PMID: 18426426BACKGROUND
  • Wan K, Lau JK, Cheung SW, Cho P. Orthokeratology with increased compression factor (OKIC): study design and preliminary results. BMJ Open Ophthalmol. 2020 May 4;5(1):e000345. doi: 10.1136/bmjophth-2019-000345. eCollection 2020.

Study Officials

  • Pauline Cho, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 28, 2015

First Posted

December 31, 2015

Study Start

June 18, 2016

Primary Completion

August 3, 2019

Study Completion

August 3, 2019

Last Updated

July 30, 2020

Record last verified: 2020-02

Locations